Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001199073-09-001017
Filing Date
2009-12-17
Accepted
2009-12-17 07:31:03
Documents
7
Period of Report
2009-09-30

Document Format Files

Seq Description Document Type Size
1 AXCAN INTERMEDIATE HOLDINGS INC. FORM 10-K d10k.htm 10-K 5384174
2 ADVANCEMENT AND INDEMNIFICATION RIGHTS LETTER AGREEMENT DATED DECEMBER 16, 2009 ex10_24.htm EX-10.24 40411
3 SUBSIDIARIES OF AXCAN INTERMEDIATE HOLDINGS INC. ex21_1.htm EX-21.1 33282
4 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302 ex31_1.htm EX-31.1 17150
5 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302 ex31_2.htm EX-31.2 17910
6 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. SECTION 1350 ex32_1.htm EX-32.1 7245
7 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C. SECTION 1350 ex32_2.htm EX-32.2 7755
  Complete submission text file 0001199073-09-001017.txt   5509723
Mailing Address 22 INVERNESS CENTER PARKWAY SUITE 310 BIRMINGHAM AL 35242
Business Address 22 INVERNESS CENTER PARKWAY SUITE 310 BIRMINGHAM AL 35242 205-991-8085
Axcan Intermediate Holdings Inc. (Filer) CIK: 0001444570 (see all company filings)

EIN.: 743249870 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-K | Act: 34 | File No.: 333-153896 | Film No.: 091246035
SIC: 2834 Pharmaceutical Preparations